[NLSP] YoY Quarter Result on 30-Jun-2024 [#Q2]

Stock
[NLSP] NLS Pharmaceutics AG
Announcement Date
18-Oct-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- -40,620.00%
YoY- 73.26%
Quarter Report
NLSP's Result
NLSP's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -2,036 -7,613 -8,641 -4,603 -1,232 -3,415 -2 216.83%
Tax 0 -0 -0 -0 -1 -2 -1 -
NP -2,036 -7,613 -8,641 -4,603 -1,232 -3,415 -2 216.83%
Tax Rate - - - - - - - -
Total Cost 2,036 7,613 8,641 4,603 1,232 3,415 2 216.83%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS 0.00 -0.20 -0.54 -0.42 -0.11 -0.31 -0.19 -
EPS Diluted 0.00 -0.20 -0.54 -0.42 -0.11 -0.31 -0.19 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.